N/A
Completed N=64
Mind-body Resiliency Intervention for Fear of Cancer Recurrence
Cancer · Coping Skills · Coping Behavior
Source: ClinicalTrials.gov NCT04876599 ↗
Enrolled (actual)
64
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcomePrimary: Feasibility: Retention Rate — 31; 31 Participants
Summary
The purpose of this study is to test the feasibility of a virtual, group mind-body resiliency intervention adapted to target fear of recurrence (FOR) among cancer survivors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility: Retention Rate |
31; 31 | — |
| PRIMARY Acceptability: 5 Item Measure of Enjoyableness, Convenience, Helpfulness, Odds of Future Use, and Overall Satisfaction |
4.33; 4.57; 4.00; 4.33; 4.20 | — |
| SECONDARY Fear of Cancer Recurrence |
23.62; 22.22; 19.74; 20.90; 20.66; 19.27 | — |
| SECONDARY Resiliency |
71.05; 75.23; 76.24; 76.80; 81.05; 75.45 | — |
Eligibility Criteria
Inclusion Criteria
- History of non-metastatic, localized, or regional solid or blood malignancy(ies)
- Completion of primary cancer treatment (i.e., radiation, surgery, chemotherapy) and/or current use of long-term maintenance hormonal or biologic therapy
- Age ≥18 years
- Elevated fear of recurrence (FCRI severity score ≥16)
- MGB/BIDMC Medical Record Number (MRN)
Exclusion Criteria
- Self-reported inability to speak and write in English
- Undertreated serious mental illness as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year
- Inability to access technology and/or sufficient internet to participate virtual groups sessions
Data sourced from ClinicalTrials.gov (NCT04876599). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.